If it wasn’t already, biotech’s pandemic IPO boom is in full swing.

After a week that saw the largest Chinese biotech IPO in history and another $154 million for a company that emerged only last September, four different biotechs raised over $200 million. Each of them upsized their offerings or priced at the top end — or more — of their original range.

Collectively, they raised $926 million, or an average of $231 million per company.

Full Article